Latest News

Are Apps the Answer? Access in Multiple Sclerosis Care
Are Apps the Answer? Access in Multiple Sclerosis Care

March 29th 2024

A feature on NeurologyLive®, IJMSC Insights offers a closer look at the latest research and the people behind it from the community of the International Journal of Multiple Sclerosis Care (IJMSC) and the Consortium of Multiple Sclerosis Centers (CMSC).

Exposure to Trichloroethylene Linked With Increased Risk of Parkinson Disease, Cancer
Exposure to Trichloroethylene Linked With Increased Risk of Parkinson Disease, Cancer

March 29th 2024

Treating NMOSD: Where Do We Go After Complement Inhibition's Success?
Treating NMOSD: Where Do We Go After Complement Inhibition's Success?

March 28th 2024

Matthew D. Czech, PhD, associate director of digital science at AbbVie
Digital Health Technologies Superior to Traditional Approaches for Measuring Disease Progression in Early Parkinson Disease

March 28th 2024

High Dose PRAX-628 Achieves Complete Response in Phase 2a Study of Photo Paroxysmal Response
High Dose PRAX-628 Achieves Complete Response in Phase 2a Study of Photo Paroxysmal Response

March 28th 2024

ACTRIMS 2024
MDA 2024
Roundtable Discussions
NeuroVoices
Mind Moments podcast
Sleeping Around the Podcast with Dr. Ann Marie Morse
Gold Standard Centers
EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD
Brain Games

Conference Coverage

View All
Aki Ko, chief executive officer at Elixirgen Therapeutics
Elixirgen Therapeutics’ Bobcat mRNA Therapeutic for Duchenne Muscular Dystrophy: Aki Ko

March 28th 2024

Nuno Mendonca, MD, chief medical officer at AC Immune SA
AC Immune SA Shares Phase 2 VacSYn Trial Update for ACI-7104.056 in Parkinson Disease

March 28th 2024

Le Hua, MD
Analyzing Cognitive Profiles in Multiple Sclerosis and Alzheimer Disease: Le Hua, MD

March 27th 2024

Amanda Peltier, MD
Integrating Genetics and Transitional Support in Muscular Dystrophy Care: Amanda Peltier, MD

March 27th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.